| Autor: |
Schwegel N; Division of Cardiology, University Heart Center Graz, Medical University of Graz, 8036 Graz, Austria., Zach D; Division of Cardiology, University Heart Center Graz, Medical University of Graz, 8036 Graz, Austria., Peikert A; Division of Cardiology, University Heart Center Graz, Medical University of Graz, 8036 Graz, Austria., Santner V; Division of Cardiology, University Heart Center Graz, Medical University of Graz, 8036 Graz, Austria., Höller V; Division of Cardiology, University Heart Center Graz, Medical University of Graz, 8036 Graz, Austria., Gollmer J; Division of Cardiology, University Heart Center Graz, Medical University of Graz, 8036 Graz, Austria., Späth J; Division of Cardiology, University Heart Center Graz, Medical University of Graz, 8036 Graz, Austria., Riepl H; Division of Cardiology, University Heart Center Graz, Medical University of Graz, 8036 Graz, Austria., Rainer PP; Division of Cardiology, University Heart Center Graz, Medical University of Graz, 8036 Graz, Austria.; Department of Medicine, St. Johann in Tirol General Hospital, 6380 St. Johann in Tirol, Austria.; BioTechMed Graz, 8010 Graz, Austria., Wallner M; Division of Cardiology, University Heart Center Graz, Medical University of Graz, 8036 Graz, Austria., Pilz S; Division of Endocrinology and Diabetology, Department of Internal Medicine, Medical University of Graz, 8036 Graz, Austria., Zirlik A; Division of Cardiology, University Heart Center Graz, Medical University of Graz, 8036 Graz, Austria., von Lewinski D; Division of Cardiology, University Heart Center Graz, Medical University of Graz, 8036 Graz, Austria., Ablasser K; Division of Cardiology, University Heart Center Graz, Medical University of Graz, 8036 Graz, Austria., Verheyen N; Division of Cardiology, University Heart Center Graz, Medical University of Graz, 8036 Graz, Austria., Kolesnik E; Division of Cardiology, University Heart Center Graz, Medical University of Graz, 8036 Graz, Austria. |
| Abstrakt: |
Background: In patients with stable chronic heart failure with a reduced ejection fraction (HFrEF), left ventricular ejection fraction (LVEF) provides limited prognostic value, especially in patients with moderately to severely reduced LVEF. Echocardiographic parameters of right ventricular function may be associated with adverse clinical events in these patients. Therefore, we analyzed 164 patients with HFrEF in a prospective single-center cohort study to evaluate whether the parameters of right ventricular function are associated with worsening heart failure (WHF) hospitalizations, cardiovascular and all-cause deaths and combined endpoints. Methods: Echocardiographic cine loops were analyzed using vendor-independent post-processing software. Multivariate Cox regression analyses were performed, which were then adjusted for clinical characteristics and left ventricular functional parameters. Results: In these models, higher tricuspid annular plane systolic excursion (TAPSE) was significantly associated with lower rates of WHF hospitalizations (HR 0.880, 95%CI 0.800-0.968, p = 0.008), a composite endpoint of WHF hospitalizations and cardiovascular death (HR 0.878, 95%CI 0.800-0.964, p = 0.006), and a composite endpoint of WHF hospitalization and all-cause death (HR 0.918, 95%CI 0.853-0.988, p = 0.023). These associations were more pronounced in patients with LVEF ≤ 35%. Conclusions: In conclusion, in patients with HFrEF, TAPSE is an independent prognosticator for adverse clinical outcomes, warranting further studies to elucidate whether incorporating TAPSE into established risk scores improves their diagnostic accuracy. |
